Mandatum Life Insurance Company’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,900
Closed -$26K 70
2022
Q4
$26K Hold
9,900
0.01% 66
2022
Q3
$37K Hold
9,900
0.01% 66
2022
Q2
$33K Hold
9,900
0.01% 74
2022
Q1
$44K Hold
9,900
0.01% 79
2021
Q4
$94K Hold
9,900
0.02% 79
2021
Q3
$167K Buy
+9,900
New +$167K 0.03% 106